<?xml version="1.0" encoding="UTF-8"?>
<p>Non-communicable diseases are on the rise causing 71% of deaths globally [
 <xref rid="B8-molecules-25-05537" ref-type="bibr">8</xref>]. Such alarming situation has prompted the need to develop new drugs to improve quality of life and decrease preventable deaths. Alzheimerâ€™s disease (AD) is a progressive neurodegenerative disorder with low acetylcholine level in the brain of patients. To date, scientists have failed to find a cure for AD due to the lack of understanding on the causes and mechanisms of the disease [
 <xref rid="B9-molecules-25-05537" ref-type="bibr">9</xref>]. As a therapeutic strategy, cholinesterase inhibitors as donepezil, rivastigmine and galantamine are prescribed to patients to help postponing the symptoms of AD, but they present significant side effects [
 <xref rid="B10-molecules-25-05537" ref-type="bibr">10</xref>,
 <xref rid="B11-molecules-25-05537" ref-type="bibr">11</xref>].
</p>
